Search

everythinglearnresearchcommunity

for

Search:↓

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Chronic telogen effluvium is a condition that causes ongoing hair shedding.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Hair is thinner near the scalp in acute hair shedding conditions.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Low zinc levels are strongly linked to hair loss in adult premenopausal women.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Low-dose oral minoxidil is a promising, safe treatment for various hair diseases, improving hair thickness and density, but more research is needed on long-term side effects and treatment duration.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Antiandrogens like spironolactone can help treat female-pattern hair loss.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Patients with chronic kidney disease on hemodialysis often have skin problems.

PRP is an effective and safe treatment for female hair loss.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.